Open-label placebo reduces fatigue in cancer survivors: a randomized trial

Overview of attention for article published in Supportive Care in Cancer, October 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#41 of 4,954)
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

So far, Altmetric has seen 12 X posts from 12 X users, with an upper bound of 30,050 followers.

@reservoir 例えばこの試験ですね。 https://t.co/yfS5rfzdml

RT @LCHeathcote: Some interesting new findings from Chris Recklitis & co suggesting efficacy of #openlabelplacebo for reducing #fatigue in…

RT @LCHeathcote: Some interesting new findings from Chris Recklitis & co suggesting efficacy of #openlabelplacebo for reducing #fatigue in…

I need to read this paper. @POCOG1 @jasmineyee_ @UTS_CST

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 8 additional X posts.